1. Balazs, T.: Cardiotoxicity of isoproterenol in experimental animals. Influence of stress, obesity, and repeated dosing. In: Recent Advances in Studies on Cardiac Structure and Metabolism, Vol. 1, p. 770–778. Myocardiology, ( E. Bajusz and G. Rona, eds.) (Baltimore 1972 ).
2. Fleckenstein, A.: Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: Calcium and the Heart, p. 135–188 ( P. Harris and L. Opie, eds. ), ( London-New York 1971 ).
3. Fleckenstein, A., J. Janke, H. J. Döring, O. Leder: Key role of Ca in the production of noncoronarogenic myocardial necroses. In: Recent Advances in Studies on Cardiac Structure and Metabolism, Vol. 6, p. 21–32. Pathophysiology and Morphology of Myocardial Cell Alterations (A. Fleckenstein and G. Rona, eds.), ( Baltimore 1975 ).
4. Hein, B., O. Pachinger, J. Janke, A. Fleckenstein: Changes in isoproterenolinduced transmembrane Ca uptake and high-energy phosphate content of the hypertrophied ventricular myocardium of rats. In: Les Surcharges Cardiaques, Collogue INSERM, p. 205–208. ( P. Y. Hatt, ed.) (Paris 1972 ).
5. Hein, B., A. Fleckenstein, J. Janke, K. Eckardt, H. J. Ludin: Einschränkung der Isoproterenol-induzierten 45Ca“-Netto-Aufnahme and der Utilisation von energiereichem Phosphat im hypertrophierten Rattenmyokard. Verh. Dtsch. Ges. Kreislaufforschg. 38, 196 (1972).